Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Middlefield Group is a prominent Canadian asset management firm with a specialized focus on the healthcare and life sciences sectors. Founded in 1979, the company manages a diverse range of investment products, including ETFs, mutual funds, and closed-end funds, many of which are dedicated to global healthcare innovation and dividend-paying medical companies. Their investment strategy emphasizes high-quality companies across pharmaceuticals, biotechnology, and healthcare services to provide investors with both income and growth. Middlefield is recognized for its expertise in navigating the complexities of the healthcare market to identify long-term value for its clients. The firm actively manages portfolios that include some of the world's leading healthcare providers and drug developers. Through its specialized funds, Middlefield provides retail and institutional investors with exposure to the defensive and growth characteristics of the global healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Middlefield Group.